Management of Peyronie’s disease: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)
The management of PD should be individualized based on the patient's needs and preferences while balancing the benefits and risks of each treatment option.
Authors
- Raouf Seyam (ORCID: https://orcid.org/0000-0002-9908-9839)
- Serkan Deveci (ORCID: https://orcid.org/0000-0002-1456-3176)
- Eric Chung (ORCID: https://orcid.org/0000-0003-3373-3668)
- Hsiao‐Han Lin (ORCID: https://orcid.org/0000-0003-2657-0821)
- Du Geon Moon (ORCID: https://orcid.org/0000-0002-9031-9845)
- Gregory A. Broderick (ORCID: https://orcid.org/0000-0003-2949-5425)
- Lawrence C. Jenkins (ORCID: https://orcid.org/0000-0003-0125-673X)
- Allen F. Morey (ORCID: https://orcid.org/0000-0001-9551-4888)
- Matt Ziegelmann
- Laurence A. Levine
Institutions
- Tulane University (US)
- Rush University Medical Center (US)
- The University of Queensland (AU)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Peking University (CN)
- Korea University Medical Center (KR)
- King Faisal Specialist Hospital & Research Centre (SA)
- Jacksonville College (US)
- Princess Alexandra Hospital (AU)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Metro South Health (AU)
- Mayo Clinic in Arizona (US)
- Texas Neurology (US)
- Peking University Third Hospital (CN)
- Biologie de la Reproduction, Environnement, Epigénétique et Développement (FR)
- Hamad Medical Corporation (QA)
- Beykent University (TR)
Publication Details
- Journal
- Sexual Medicine Reviews
- Published
- 2025-11-15
- DOI
- https://doi.org/10.1093/sxmrev/qeaf068
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00